Badawi David 4
4 · Sight Sciences, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) CTO David Badawi Sells 7,418 Shares
What Happened
- David Badawi, Chief Technology Officer and a director of Sight Sciences (SGHT), sold 7,418 shares of common stock in open-market/private sale on 2026-07-06. The weighted average sale price was $5.51, for total proceeds of approximately $40,858. The filing indicates the sale was to cover the Reporting Person’s tax liability related to RSU vesting.
Key Details
- Transaction date: 2026-07-06.
- Shares sold: 7,418; weighted avg price: $5.51; total ≈ $40,858.
- Per the filing, sale prices ranged from $5.37 to $5.62 across multiple transactions; the filer can provide per-price breakdown on request.
- Reason: Sale effectuated to cover tax withholding on vested RSUs (tax-withholding sale).
- Shares owned after transaction: beneficially owns 1,813,950 shares and has 168,922 RSUs that will convert upon vesting (total potential 1,982,872).
- Filing date/reporting period: 2026-07-06 (same-day report shown).
Context
- This was a sell-to-cover tax withholding related to RSU vesting (routine administrative sale) rather than a discretionary divestiture; such sales are common after awards vest and do not necessarily signal management’s view on the company’s outlook.
Insider Transaction Report
Form 4
Badawi David
DirectorChief Technology Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-07-06$5.51/sh−7,418$40,858→ 1,982,872 total
Footnotes (3)
- [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
- [F2]Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes (i) 1,813,950 shares of Common Stock, and (ii) 168,922 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi|2026-07-06